AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 24532827
Drug: Multitiered intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multitiered intervention with enhanced core reading instruction and additional 30-min daily small group intervention
Trial: 12026536
Drug: SIT (Specific
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SIT (Specific Immunotherapy) with mixed grass pollen allergens (Allergovit, Pollinex)
Trial: 12026536
Drug: SIT (Specific
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SIT (Specific Immunotherapy) with mixed grass pollen allergens
Trial: 9824782
Drug: Intravenous morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous morphine 0.05 mg/kg (3.5 mg for 70-kg body weight)
Trial: 31155392
Drug: Hydrocortisone (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone (0.5 mg/kg/6 hours)
Trial: 9222076
Drug: Trovafloxacin 100
RxNorm normalized name: trovafloxacin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trovafloxacin 100 mg tablets (fasted)
Trial: 9222076
Drug: Alatrofloxacin (IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alatrofloxacin (IV infusion)
Trial: 9222076
Drug: Trovafloxacin 100
RxNorm normalized name: trovafloxacin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trovafloxacin 100 mg tablets (after standard breakfast)
Trial: 9222076
Drug: Trovafloxacin 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trovafloxacin 300 mg oral aqueous suspension (fasted)
Trial: 8107542
Drug: Rehydration with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rehydration with 1.5 l of water over 2 h after 24 h of dehydration
Trial: 3105747
Drug: Normal protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal protein diet (median 92 g/day)
Trial: 3105747
Drug: Low protein
RxNorm normalized name: Low protein mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low protein diet (47 g/day)
Trial: 24472873
Drug: Intensive insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive insulin therapy targeting normal‐for‐age fasting blood glucose concentrations
Trial: 24472873
Drug: Insulin infusion
RxNorm normalized name: iLet Insulin Infusion 10-Pack Kit Inset
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin infusion only to prevent excessive hyperglycemia
Trial: 12234955
Drug: Paxil (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paxil (20 mg/d) for 6 weeks
Trial: 9637806
Drug: Metformin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin plus Clomiphene
Trial: 21063110
Drug: Syzygium cumini
RxNorm normalized name: SYZYGIUM CUMINI SEED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Syzygium cumini aqueous leaves extract (ASc) at 100 μg/mL
Trial: 21063110
Drug: Syzygium cumini
RxNorm normalized name: SYZYGIUM CUMINI SEED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Syzygium cumini aqueous leaves extract (ASc) at 200 μg/mL
Trial: 17409123
Drug: Bed Rest
RxNorm normalized name: Rest Simply
DrugBank: Diphenhydramine (DB01075)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bed Rest plus Essential Amino Acid and Carbohydrate Supplement (BRAA)
Trial: 2570286
Drug: UK 69
RxNorm normalized name: UK-390957
DrugBank: UK-390957 (DB11719)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UK 69 578 (a competitive inhibitor of endopeptidase 24.11)
Trial: 1096122
Drug: Nystatin cream
RxNorm normalized name: Nystatin Cream
DrugBank: Nystatin (DB00646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nystatin cream
Trial: 326494
Drug: Nystatin/triamcinolone acetonide
RxNorm normalized name: nystatin/triamcinolone acetonide TOPICAL CREAM (GRAM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nystatin/triamcinolone acetonide combination cream
Trial: 23474890
Drug: Codeine/Paracetamol 20/400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Codeine/Paracetamol 20/400 mg
Trial: 23474890
Drug: Codeine/Paracetamol 40/800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Codeine/Paracetamol 40/800 mg
Trial: 23474890
Drug: Codeine/Paracetamol 60/1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Codeine/Paracetamol 60/1200 mg
Trial: 15067655
Drug: Bupivacaine 20
RxNorm normalized name: BUPIVACAINE 200MG/MELOXICAM 6MG/VIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 20 mL 0.5% (100 mg)
Trial: 3290233
Drug: Antimicrobial agent
RxNorm normalized name: GAUZE,ANTIMICROBIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimicrobial agent
Trial: 21440263
Drug: Conventional preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional preparation of the other leg
Trial: 20038402
Drug: Peri-interventional antibiotic
RxNorm normalized name: casanthranol / docusate sodium Oral Capsule [Peri-Colace]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peri-interventional antibiotic treatment with cefuroxime, 20 mg/kg three times per day for 24 hours
Trial: 20038402
Drug: Prolonged antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged antibiotic treatment with cefuroxime, 20 mg/kg three times per day for 7 days
Trial: 15329902
Drug: Pegylated liposomal
RxNorm normalized name: doxorubicin HCl pegylated liposomal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pegylated liposomal doxorubicin at 50 mg/m2 every 4 weeks for 6 cycles (Group B)
Trial: 15329902
Drug: Pegylated liposomal
RxNorm normalized name: doxorubicin HCl pegylated liposomal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pegylated liposomal doxorubicin at 25 mg/m2 every 2 weeks for 12 cycles (Group A)
Trial: 15329902
Drug: Group B
RxNorm normalized name: Blood group B IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group B (50 mg/m2 every 4 weeks for 6 cycles)
Trial: 15329902
Drug: Group A
RxNorm normalized name: Blood group A IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group A (25 mg/m2 every 2 weeks for 12 cycles)
Trial: 11061509
Drug: Arginine (ARG;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arginine (ARG; 0.5 g/kg, iv, from 0-30 min)
Trial: 2868337
Drug: Intravenous streptokinase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous streptokinase (SK) in addition to usual treatment
Trial: 2868337
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (usual treatment only)
Trial: 24999127
Drug: Surgical tracheostomy
RxNorm normalized name: TRACHEOSTOMY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical tracheostomy (ST) using Charles G Durbin technique
Trial: 22874424
Drug: High-carbohydrate beverage
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-carbohydrate beverage (3.4 g glucose + 3.1 g fructose per deciliter)
Trial: 22874424
Drug: Control beverage
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control beverage (0.0 g glucose + 0.0 g fructose per deciliter)
Trial: 22874424
Drug: Low-carbohydrate beverage
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-carbohydrate beverage (1.7 g glucose + 1.6 g fructose per deciliter)
Trial: 15879435
Drug: Albuterol (beta-agonist)
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol (beta-agonist) with glucocorticoid
Trial: 14673758
Drug: Granulocyte-macrophage colony-stimulating
RxNorm normalized name: Granulocyte macrophage-colony stimulating factor
DrugBank: Molgramostim (DB12525)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granulocyte-macrophage colony-stimulating factor (GM-CSF) 250 microg administered subcutaneously 3 times/week for 16 weeks
Trial: 8883267
Drug: Intravenous heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous heparin (5000 U bolus followed by 1000 U/h infusion)
Trial: 8883267
Drug: Subcutaneous heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous heparin (12,500 U every 12 h, started 4 h after streptokinase)
Trial: 6091079
Drug: Antacid preparations
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antacid preparations
Trial: 30183260
Drug: Hydrogel formulation
RxNorm normalized name: Hydrogen
DrugBank: Hydrogen (DB15127)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrogel formulation of dapivirine
Trial: 30183260
Drug: Film-based formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Film-based formulation of dapivirine
Trial: 20416132
Drug: Quercetin 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quercetin 150 mg per day for 6 weeks
Trial: 18092452
Drug: LANAP treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LANAP treatment with Nd:YAG laser
Trial: 18092452
Drug: Control treatment
RxNorm normalized name: SALICYLIC ACID 190 mg in 1 mL TOPICAL LIQUID [Derma E Acne Blemish Control Treatment Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control treatment (scaling and root planing without laser)
Trial: 12632439
Drug: Corticosteroid injection
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid injection (triamcinolone hexacetonide 40 mg) + supervised physiotherapy
Trial: 12632439
Drug: Corticosteroid injection
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid injection alone
Trial: 12632439
Drug: Saline injection
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline injection + supervised physiotherapy
Trial: 12632439
Drug: Saline injection
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline injection alone (placebo group)
Trial: 8719534
Drug: Local anesthetic
RxNorm normalized name: Local anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local anesthetic cream (EMLA)
Trial: 1827575
Drug: Medroxyprogesterone acetate
RxNorm normalized name: Medroxyprogesterone Acetate
DrugBank: Medroxyprogesterone acetate (DB00603)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medroxyprogesterone acetate (MPA) 1,200 mg/day (Group A: 28 patients)
Trial: 1827575
Drug: Cyclophosphamide (CPA)
DrugBank: Cyclophosphamide (DB00531)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Cyclophosphamide (CPA) 100 mg/day in combination with MPA (Group B: 20 patients)
Trial: 1827575
Drug: Medroxyprogesterone acetate
RxNorm normalized name: Medroxyprogesterone Acetate
DrugBank: Medroxyprogesterone acetate (DB00603)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medroxyprogesterone acetate (MPA) 1,200 mg/day (Group A)
Trial: 1827575
Drug: Cyclophosphamide (CPA)
DrugBank: Cyclophosphamide (DB00531)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Cyclophosphamide (CPA) 100 mg/day in combination with MPA (Group B)
Trial: 7387963
Drug: Xenon arc
RxNorm normalized name: xenon
DrugBank: Xenon (DB13453)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xenon arc photocoagulation treatment
Trial: 28096223
Drug: Basal plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basal plus prandial insulin therapy
Trial: 21991732
Drug: Ketamine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (0.5 mg/kg) + Bupivacaine (5 mg/ml)
Trial: 21991732
Drug: Meperidine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meperidine (1 mg/kg) + Bupivacaine (5 mg/ml)
Trial: 19438906
Drug: Pegvisomant monotherapy
RxNorm normalized name: Pegvisomant
DrugBank: Pegvisomant (DB00082)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Pegvisomant monotherapy (PM) - 10 mg once daily initially, adjusted in 5-mg increments every 8 weeks based on IGF‐I levels
Trial: 19438906
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy of pegvisomant and long-acting octreotide (P-LAR) - LAR dosing remained fixed
Trial: 17276147
Drug: Once daily
RxNorm normalized name: GEL, ONCE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once daily (OD) tobramycin
Trial: 17276147
Drug: Three times
RxNorm normalized name: WELLBUTRIN 100 MG Oral Tablet, Three Times Daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three times daily (TD) tobramycin
Trial: 8751024
Drug: Jet-injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jet-injection of recombinant human growth hormone (rhGH)
Trial: 8751024
Drug: Needle-injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Needle-injection of recombinant human growth hormone (rhGH)
Trial: 8751024
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (jet-injection and needle-injection)
Trial: 2208022
Drug: Lower doses
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower doses of chemotherapy
Trial: 31403507
Drug: Inhaled nitrous
RxNorm normalized name: nitrous oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitrous oxide (N2O)
Trial: 28272716
Drug: NBCA medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NBCA medical adhesive for patch fixation
Trial: 28272716
Drug: Without patch
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Without patch fixation (control group)
Trial: 21353720
Drug: G-CSF administered
RxNorm normalized name: G-CSF
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-CSF administered concurrently with radiotherapy (RT)
Trial: 19210693
Drug: darunavir/RTV 800/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: darunavir/RTV 800/100 mg qd
Trial: 19210693
Drug: atazanavir/RTV 300/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: atazanavir/RTV 300/100 mg qd
Trial: 9548039
Drug: Sedation with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sedation with intravenous midazolam (5 mg for those under 65 years or 3 mg for those aged 65 or more)
Trial: 23210197
Drug: Chlorhexidine (CHX)
RxNorm normalized name: chlorhexidine gluconate Topical Solution [CHX Plus]
DrugBank: Chlorhexidine (DB00878)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorhexidine (CHX) gel
Trial: 22113220
Drug: Navigated treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Navigated treatment (Group B)
Trial: 19772268
Drug: Early laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early laser photocoagulation treatment
Trial: 12174103
Drug: Cipamfylline (0.15%)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cipamfylline (0.15%) cream
Trial: 12174103
Drug: Hydrocortisone 17-butyrate
RxNorm normalized name: Cortisol 17-butyrate
DrugBank: Hydrocortisone butyrate (DB14540)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrocortisone 17-butyrate (0.1%) cream
Trial: 7648380
Drug: Uni-Dur 800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uni-Dur 800 mg once-daily
Trial: 7648380
Drug: Uni-Dur 400
RxNorm normalized name: Uni-Dur 400 MG Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uni-Dur 400 mg twice-daily
Trial: 7648380
Drug: Uniphyl 800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uniphyl 800 mg once-daily
Trial: 2704503
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg 17 beta‐estradiol + norethisterone acetate 1 mg
Trial: 2704503
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg 17 beta‐estradiol + megestrol acetate 5 mg
Trial: 2704503
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg 17 beta‐estradiol + norethisterone acetate 0.5 mg
Trial: 2704503
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg 17 beta‐estradiol + megestrol acetate 2.5 mg
Trial: 23258626
Drug: Testosterone patch
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone patch for 36 months
Trial: 25100359
Drug: Placebo patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo patch for 36 months
Trial: 19549428
Drug: Loratadine/montelukast (L/M;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loratadine/montelukast (L/M; 10 mg/10 mg)
Trial: 17258304
Drug: Inhaled corticosteroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled corticosteroids (ICSs) for 48 months or more
Trial: 17258304
Drug: Nonusers of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonusers of inhaled corticosteroids (ICSs)
Trial: 17258304
Drug: Inhaled corticosteroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled corticosteroids (ICSs) for 4 years or more in subjects with high total IgE (>100 kU/L)
Trial: 17258304
Drug: Inhaled corticosteroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled corticosteroids (ICSs) in subjects with lower total IgE
Trial: 15606733
Drug: 5% imiquimod
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% imiquimod cream applied 5 times/week for 4 weeks
Trial: 15606733
Drug: 5% imiquimod
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% imiquimod cream applied 5 times/week for 6 weeks
Trial: 23712737
Drug: levamisole (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: levamisole (5 mg/rat/day)
Trial: 22117578
Drug: Standard medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard medical treatment and care (Control group)
Trial: 19326108
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate (CaCO(3), n = 8), 500 mg bid
Trial: 17728427
Drug: Aripiprazole (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aripiprazole (10 mg, 15 mg, 20 mg, or 30 mg)
Trial: 15054430
Drug: Two portions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two portions (300 g) of fruits and vegetables daily
Trial: 15054430
Drug: Five portions
RxNorm normalized name: fivehorn smotherweed pollen extract
DrugBank: Bassia hyssopifolia pollen (DB10941)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Five portions (750 g) of fruits and vegetables daily
Trial: 9695991
Drug: Ursodeoxycholate (UDC)
RxNorm normalized name: ursodeoxycholate
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholate (UDC) treatment
Trial: 8016587
Drug: Low energy
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low energy laser (LEL) treatment
Trial: 2699615
Drug: Flatulence treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flatulence treatment
Trial: 769971
Drug: DTIC (NSC-45388)
DrugBank: Dacarbazine (DB00851)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: DTIC (NSC-45388) with other drugs
Trial: 769971
Drug: DTIC (NSC-45388)
DrugBank: Dacarbazine (DB00851)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: DTIC (NSC-45388) as an adjuvant to standard surgical therapy
Trial: 26972526
Drug: Movement imitation
RxNorm normalized name: BERGAMOT,IMITATION
DrugBank: Bergamot oil (DB14335)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Movement imitation therapy (experimental group)
Trial: 20413299
Drug: Cetuximab treatment
RxNorm normalized name: Cetuximab
DrugBank: Cetuximab (DB00002)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Cetuximab treatment in KRAS wild type patients
Trial: 20413299
Drug: No cetuximab
RxNorm normalized name: Cetuximab
DrugBank: Cetuximab (DB00002)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: No cetuximab treatment in KRAS wild type patients (control group)
Trial: 16135348
Drug: 0.0625% bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.0625% bupivacaine plus fentanyl (BF) 3 microg/mL
Trial: 10065895
Drug: Heparin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (50 IU/kg)
Trial: 2126738
Drug: Leuprolide +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leuprolide + Flutamide (L + F)
Trial: 2126738
Drug: Leuprolide (L)
DrugBank: Leuprolide (DB00007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leuprolide (L) alone
Trial: 7021263
Drug: Amoxycillin administered
RxNorm normalized name: Amoxycillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxycillin administered twice daily (50 mg/kg body-weight/day)
Trial: 7021263
Drug: Amoxycillin administered
RxNorm normalized name: Amoxycillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxycillin administered four times daily (50 mg/kg body-weight/day)
Trial: 31398066
Drug: Facemask therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Facemask therapy (FM group)
Trial: 31398066
Drug: Facemask therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Facemask therapy with a miniscrew (FM+MS group)
Trial: 24521647
Drug: Biapenem (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biapenem (300 mg every 12 h)
Trial: 11743708
Drug: Cognitive behaviour
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behaviour therapy (active treatment)
Trial: 11743708
Drug: Traditional symptom
RxNorm normalized name: Pamprin Multi-Symptom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional symptom alleviation (passive treatment)
Trial: 9924711
Drug: Azithromycin 500
RxNorm normalized name: azithromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin 500 mg orally once daily for 3 days (n = 150)